
SQANTI characterization of the corrected PacBio transcriptome. (A) Length of the reference transcripts to which FSM, ISM, and UTR3 Fragment PacBio transcripts matched. (B) Length of PacBio transcripts by SQANTI categories. (C) Overlap at 3′ and (D) 5′ ends between the FSM transcripts and their respective matched reference transcripts. (TTS) transcription termination site, (TSS) transcription start site. (E) Percentage of monoexonic and multi-exonic transcripts for transcripts belonging to novel genes and annotated genes. (F) Transcript expression distribution across SQANTI categories.











